ArticlePloS one2018

Gene expression assay and Watson for Oncology for optimization of treatment in ER-positive, HER2-negative breast cancer.

Yun Yeong Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.